EyePoint Pharmaceuticals, Inc. (EYPT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.34B |
| Enterprise Value | 1.26B |
| P/E Ratio | -3.92 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 151.17 |
| Price/Book Ratio | 5.12 |
| Enterprise/Revenue | 143.62 |
| Enterprise/EBITDA | -4.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -35.67 |
| Operating Margin | -37.01 |
| Return On Assets | -0.94 |
| Return On Equity | -1.11 |
| Revenue | 31.37M |
| Revenue/Share | 0.09 |
| Gross Profit | 29.31M |
| EBITDA | -229.34M |
| Net Income | -231.96M |
| Diluted EPS | -3.17 |
| Total Cash | 222.55M |
| Total Cash/Share | 2.59 |
| Total Debt | 20.23M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 6.66 |
| Book Value Per Share | 2.68 |
| 52-Week Change | 65.82 |
| 52-Week High | 19.11 |
| 52-Week Low | 8.36 |
| Moving Average 50 Days | 13.27 |
| Moving Average 200 Days | 14.11 |
| Average Volume | 958,891 |
| Shares Outstanding | 83.84M |
| % Held by Institutions | 106.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 09, 2020 |